These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
120 related items for PubMed ID: 77180
21. Comparison of two non-cross-resistant combinations (ABVP/LOPP) with COPP plus bleomycin in the treatment of advanced Hodgkin's disease. Koza I, Bohunický L, Mociková K, Gyárfás J, Svancárová L, Mardiak J, Spánik S, Fuchsberger P, Thalmeinerová Z, Sufliarsky J. Neoplasma; 1991; 38(6):583-93. PubMed ID: 1722564 [Abstract] [Full Text] [Related]
22. Long-term follow-up with ABDIC salvage chemotherapy of MOPP-resistant Hodgkin's disease. Tannir N, Hagemeister F, Velasquez W, Cabanillas F. J Clin Oncol; 1983 Jul; 1(7):432-9. PubMed ID: 6199478 [Abstract] [Full Text] [Related]
26. Combination chemotherapy for stage IV Hodgkin's disease (Report no 14). Goldman JM. Clin Radiol; 1981 Sep; 32(5):531-6. PubMed ID: 6168426 [Abstract] [Full Text] [Related]
27. Pediatric Hodgkin's disease. Oliapuram Jose B, Koerner P, Bertolone S, Patel CC, Spanos WJ, Paris KJ, Silverman CL, Yashar CM. J Ky Med Assoc; 2004 Mar; 102(3):104-6. PubMed ID: 15067795 [Abstract] [Full Text] [Related]
28. Drug selection in the treatment of Hodgkin's disease. Bonadonna G, Santoro A. Hematol Oncol; 1983 Mar; 1(1):3-12. PubMed ID: 6203820 [No Abstract] [Full Text] [Related]
29. Etoposide, vinblastine, and doxorubicin: an active regimen for the treatment of Hodgkin's disease in relapse following MOPP. Cancer and Leukemia Group B. Canellos GP, Petroni GR, Barcos M, Duggan DB, Peterson BA. J Clin Oncol; 1995 Aug; 13(8):2005-11. PubMed ID: 7636541 [Abstract] [Full Text] [Related]
30. Vancouver hybrid: preliminary experience in the treatment of Hodgkin's disease in childhood and adolescence. Khan SP, Gilchrist GS, Arndt CA, Smithson WA, Chen MG, Schomberg PJ, Matsumoto JM, O'Fallon WM. Mayo Clin Proc; 1994 Oct; 69(10):949-54. PubMed ID: 7523802 [Abstract] [Full Text] [Related]
31. Combined modality therapy in previously untreated patients with advanced Hodgkin's disease: A 24-year follow-up study. Salloum E, Doria R, Farber LR, Roberts KB, Cooper DL. Cancer J Sci Am; 1995 Oct; 1(4):267-73. PubMed ID: 9166487 [Abstract] [Full Text] [Related]
32. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma]. Fu XH, Wang SS, Huang Y, Wang B, Huang HQ, Zhang L, Sun XF, Xu RH, Lin TY. Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685 [Abstract] [Full Text] [Related]
35. Combination chemotherapy of advanced previously treated Hodgkin's disease with streptozotocin, CCNU, adriamycin and bleomycin. Levi JA, Wiernik PH, Diggs CH. Med Pediatr Oncol; 1977 Aug; 3(1):33-40. PubMed ID: 65727 [Abstract] [Full Text] [Related]
36. Can MOPP be replaced in the treatment of advanced Hodgkin's disease? Canellos GP. Semin Oncol; 1990 Feb; 17(1 Suppl 2):2-6. PubMed ID: 1689509 [Abstract] [Full Text] [Related]
37. Alternating non-cross-resistant combination chemotherapy or MOPP in stage IV Hodgkin's disease. A report of 8-year results. Bonadonna G, Valagussa P, Santoro A. Ann Intern Med; 1986 Jun; 104(6):739-46. PubMed ID: 2422994 [Abstract] [Full Text] [Related]
38. Vinblastine, bleomycin, and cis-platin as salvage therapy for MOPP treated patients with Hodgkin's lymphoma. Corder MP, Clamon GH, Wiesenfeld M. Cancer Invest; 1984 Jun; 2(3):193-8. PubMed ID: 6203626 [Abstract] [Full Text] [Related]
39. Eight-drug combination chemotherapy (MOPP and ABDV) and local radiotherapy for advanced Hodgkin's Disease. Case DC, Young CW, Nisce L, Lee BJ, Clarkson BD. Cancer Treat Rep; 1976 Sep; 60(9):1217-23. PubMed ID: 65221 [Abstract] [Full Text] [Related]